| 标题 |
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:M. Roupret; Aurélie Bertaut; G. Pignot; Y. Neuzillet; N. Houede; et al 出版日期:2025-10-17 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)